Key result
Inhibition of P38 MAPK, GSK3β, and astrocyte-specific knockout of NLRP3 ameliorated cognitive impairment behaviors induced by abdominal surgery and anesthesia in aged mice.
Why the study?
Building on prior research linking postoperative mood fluctuations and cognitive dysfunction with P38 phosphorylation, this study investigated the involvement of the P38 MAPK/NLRP3 pathway in perioperative neurocognitive disorders in an aged mice model.
Does inhibition of the P38 MAPK/NLRP3 pathway improve cognitive dysfunction in aged mice after abdominal surgery?
Does inhibition of the P38 MAPK/NLRP3 pathway improve cognitive dysfunction in aged mice after abdominal surgery?
Inhibition of the P38 MAPK/NLRP3 pathway mitigates postoperative cognitive dysfunction in aged mice but may induce adverse mood alterations, highlighting the complexity of targeting this pathway for perioperative neurocognitive disorders.
May implicate P38 MAPK/NLRP3 in postoperative cognitive dysfunction; leaves open human translation and trials.
Background Cognitive dysfunction, encompassing perioperative psychological distress and cognitive impairment, is a prevalent postoperative complication within the elderly population, and in severe cases, it may lead to dementia. Building upon our prior research that unveiled a connection between postoperative mood fluctuations and cognitive dysfunction with the phosphorylation of P38, this present investigation aims to delve deeper into the involvement of the P38 MAPK/NLRP3 pathway in perioperative neurocognitive disorders (PND) in an abdominal exploratory laparotomy (AEL) aged mice model. Methods C57BL/6 mice (male, 18-month-old) underwent AEL with 3% anesthesia. Then, inhibitors targeting P38 MAPK (SB202190, 1 mg/kg) and GSK3β (TWS119, 10 mg/kg) were administered multiple times daily for 7 days post-surgery. The NLRP3-cKO AEL and WT AEL groups only underwent the AEL procedure. Behavioral assessments, including the open field test (OFT), novel object recognition (NOR), force swimming test (FST) and fear conditioning (FC), were initiated on postoperative day 14. Additionally, mice designated for neuroelectrophysiological monitoring had electrodes implanted on day 14 before surgery and underwent novel object recognition while their local field potential (LFP) was concurrently recorded on postoperative day 14. Lastly, after they were euthanasized, pathological analysis and western blot were performed. Results SB202190, TWS119, and astrocyte-conditional knockout NLRP3 all ameliorated the cognitive impairment behaviors induced by AEL in mice and increased mean theta power during novel location exploration. However, it is worth noting that SB202190 may exacerbate postoperative depressive and anxiety-like behaviors in mice, while TWS119 may induce impulsive behaviors. Conclusions Our study suggests that anesthesia and surgical procedures induce alterations in mood and cognition, which may be intricately linked to the P38 MAPK/NLRP3 pathway.
No takes yet. Share an insight, caveat, or question.
Lv et al. (2024) studied Perioperative neurocognitive disorders (PND) (n=312). P38 MAPK inhibitor (SB202190), GSK3β inhibitor (TWS119), and astrocyte-specific NLRP3 knockout vs. Vehicle or Wild-type mice was evaluated on Cognitive impairment behaviors (novel object recognition and fear conditioning). Inhibition of P38 MAPK, GSK3β, and astrocyte-specific knockout of NLRP3 ameliorated cognitive impairment behaviors induced by abdominal surgery and anesthesia in aged mice.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: